Clavanin A vs Pleurocidin
Head-to-head comparison of Clavanin A (Clavanin A (tunicate-derived antimicrobial peptide)) and Pleurocidin (Pleurocidin (winter flounder antimicrobial peptide)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
Clavanin A
4.4
Pleurocidin
4.5
| Property | Clavanin A | Pleurocidin |
|---|---|---|
| Category | Marine-Derived | Marine-Derived |
| Full Name | Clavanin A (tunicate-derived antimicrobial peptide) | Pleurocidin (winter flounder antimicrobial peptide) |
| Molecular Weight | ~2.6 kDa | ~2.8 kDa |
| Half-Life | NR | NR |
| Amino Acids | 23 | 25 |
| Typical Dose | NR | NR |
| Route | in vitro|topical preclinical | in vitro|topical preclinical |
| Purity | ≥98% | ≥98% |
| Studies Count | 83 | 82 |
| Research Status | Pre-clinical | Pre-clinical |
Clavanin A Benefits
- ✓antibacterial
- ✓anti-inflammatory
- ✓wound-healing lead
Pleurocidin Benefits
- ✓antimicrobial
- ✓anticancer lead
- ✓endotoxin neutralization
Clavanin A Dosing
NR|NR
Pleurocidin Dosing
NR|NR
Clavanin A Side Effects
- ⚠hemolysis at high concentrations
- ⚠immunogenicity risk
- ⚠protease sensitivity
Pleurocidin Side Effects
- ⚠membrane toxicity
- ⚠hemolysis at high concentrations
- ⚠protease sensitivity
Research Overview
Clavanin A
Preclinical work supports broad antibacterial activity and some host-modulating effects, especially in skin and wound models. Activity can be improved through sequence optimization and formulation strategies.
Pleurocidin
Preclinical studies report membrane-active killing of bacteria and some activity against cancer cell lines. Multiple analogs have been developed to reduce toxicity while preserving potency.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.
Related Comparisons
Common Stacking Partners
Clavanin A stacks with:
Clavanin
Pleurocidin stacks with:
Pleurocidin
marine-derivedantimicrobial peptidebioactive peptide